EDVA
AMEX HealthcareEndovia Health Sciences, Inc.
$0.19
$0.00 (+1.32%)
Live quote
52w: $0.17 – $13.40
Loading chart…
P/E Ratio—
P/B Ratio—
EV/EBITDA—
Debt/Equity—
ROE—
ROIC—
Revenue Growth-90.88%
Gross Margin23.13%
Endovia Health Sciences is a diversified cannabinoid-based health sciences platform. The company's strategy focuses on three main areas: commercializing differentiated cannabinoid-based pharmaceutical products internationally, advancing cannabinoid-based human and veterinary therapeutics through U.S. regulatory pathways, and developing consumer wellness and beverage products. This marks a strategic transformation from its prior operations as a beverage company.
Own EDVA? Track it here.
Create a free account to add EDVA to a portfolio and watch your P/L update in real time.
Custom screens, valuation models and backtesting are coming to Pro.